Healthineers lifted on the back of the strong performance in Q4 of CY 20 and its FY guidance. But one of the drivers, if not more, look slightly fragile to us: normalisation of the underlying business. The latter might be really attributable to the more machine-related divisions, but for Diagnostics we have some doubts. Released preliminary figures were stronger than expected and also beat consensus.